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ABSTRACT The global spread of antibiotic resistance among Enterobacteriaceae is
largely due to multidrug resistance plasmids that can transfer between different bac-
terial strains and species. Horizontal gene transfer of resistance plasmids can compli-
cate hospital outbreaks and cause problems in epidemiological tracing, since tracing
is usually based on bacterial clonality. We have developed a method, based on opti-
cal DNA mapping combined with Cas9-assisted identification of resistance genes,
which is used here to characterize plasmids during an extended-spectrum -
lactamase (ESBL)-producing Enterobacteriaceae outbreak at a Swedish neonatal in-
tensive care unit. The outbreak included 17 neonates initially colonized with ESBL-
producing Klebsiella pneumoniae (ESBL-KP), some of which were found to carry
additional ESBL-producing Escherichia coli (ESBL-EC) in follow-up samples. We dem-
onstrate that all ESBL-KP isolates contained two plasmids with the blaCTX-M-15 gene
located on the smaller one (~80 kbp). The same ESBL-KP clone was present in
follow-up samples for up to 2 years in some patients, and the plasmid carrying the
blaCTX-M-15 gene was stable throughout this time period. However, extensive genetic
rearrangements within the second plasmid were observed in the optical DNA maps
for several of the ESBL-KP isolates. Optical mapping also demonstrated that even
though other bacterial clones and species carrying blaCTX-M group 1 genes were
found in some neonates, no transfer of resistance plasmids had occurred. The data
instead pointed toward unrelated acquisition of ESBL-producing Enterobacteriaceae
(EPE). In addition to revealing important information about the specific outbreak, the
method presented is a promising tool for surveillance and infection control in clini-
cal settings.
IMPORTANCE This study presents how a novel method, based on visualizing single
plasmids using sequence-specific fluorescent labeling, could be used to analyze the
genetic dynamics of an outbreak of resistant bacteria in a neonatal intensive care
unit at a Swedish hospital. Plasmids are a central reason for the rapid global spread
of bacterial resistance to antibiotics. In a single experimental procedure, this method
replaces many traditional plasmid analysis techniques that together provide limited
details and are slow to perform. The method is much faster than long-read whole-
genome sequencing and offers direct genetic comparison of patient samples. We
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could conclude that no transfer of resistance plasmids had occurred between differ-
ent bacteria during the outbreak and that secondary cases of ESBL-producing Enter-
obacteriaceae carriage were instead likely due to influx of new strains. We believe
that the method offers potential in improving surveillance and infection control of
resistant bacteria in hospitals.
KEYWORDS CRISPR/Cas9, optical DNA mapping, antibiotic resistance, intensive care
unit, plasmids
Antimicrobial resistance (AMR) is increasing worldwide and represents a majorthreat to human health (1). The World Health Organization (WHO) defines AMR as
a key priority for reducing mortality due to infectious disease in the Sustainable
Developmental Goals from 2014 (2). Hospital settings are particularly vulnerable to the
effects of AMR due to the high prevalence of bacterial infections, high antibiotic use,
immunocompromised patients, and transmission of bacteria between patients, some-
times with hospital staff as a vector. The increasing prevalence of nosocomial outbreaks
caused by extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae (EPE)
or carbapenemase-producing Enterobacteriaceae (CPE) in high-risk wards, such as
intensive care units (ICUs) and neonatal intensive care units (NICUs), is particularly
problematic. Around 30% of global neonatal deaths are caused by bacteria resistant to
antimicrobials (3), and neonatal sepsis is causing around one million deaths annually
(2). Actions to improve surveillance and to rapidly control outbreaks in these settings
are essential, since invasive infections with EPE among highly sensitive patients are
associated with high morbidity and mortality (4, 5). Methods for identification and
genotyping of bacterial isolates have been improved and become faster and more
efficient during the last decade. Pulsed-field gel electrophoresis (PFGE) and PCR fin-
gerprinting have been complemented by multilocus sequence typing (MLST) and
whole-genome sequencing (WGS). However, currently used methods still require sig-
nificant hands-on time and usually have the capability of detecting only clonal spread
of resistant bacteria. In case of EPE and CPE, horizontal transfer of resistance genes on
plasmids presents a further complicating factor, since it will not be detected by
traditional typing techniques used at the strain level.
Plasmids are large, circular DNA molecules that are not part of the chromosomal
DNA of the bacteria, and in the case of clinical isolates, they often carry multiple
resistance genes. For clinical surveillance, traditional methods for plasmid typing are
either slow or provide limited information (6). Whole-genome sequencing generates
complete genetic information, but short-read sequencing methodologies are unable to
generate complete plasmid contigs due to the prevalence of repetitive elements, and
in order to obtain complete plasmid sequences for comparison, long-read technologies
have to be used, and these methods are still not used in clinical routine as often as
short-read technologies. Therefore, there is a need for rapid and straightforward
epidemiological tools to detect plasmid transfer in ICU and NICU settings.
We have developed a method, based on optical DNA mapping (7, 8), for character-
ization of bacterial plasmids. By adding two molecules, the fluorescent YOYO-1 and the
non-fluorescent AT-selective netropsin, we form an emission intensity variation along
the DNA that reflects the underlying sequence, where AT-rich regions are dark and
GC-rich regions are bright (9, 10). To visualize this variation in emission intensity, the
DNA barcode, we stretch single intact plasmids in nanochannels and image them using
fluorescence microscopy (8). We have demonstrated that the method can with high
confidence measure the number and sizes of all large plasmids in a bacterial cell (11)
and produce a unique barcode for each plasmid that can be used to identify conju-
gation of plasmids between different strains and species of bacteria (12–14). The
method can also identify previously sequenced plasmids by comparing experimental
barcodes with theoretical barcodes of the thousands of plasmids in the NCBI public
database (15). In our latest improvement of the assay, we incorporated the CRISPR/Cas9
system to demonstrate on which plasmid a specific (resistance) gene is located (16).
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Thus, we now have a method that can, in a single experiment, yield information that
traditionally requires several different, time-consuming techniques, such as S1/PFGE,
PCR, Southern blotting, or long-read whole-genome sequencing. Importantly, our assay
can potentially yield sequence information within hours instead of days from initial
sample to complete results and is therefore ideal for rapid tracing, for example, in
hospital outbreaks.
In this study, we use the assay to study spread of EPE between neonates and
potential plasmid spread between colonizing EPE bacteria during a nosocomial out-
break at the NICU at Karolinska University Hospital in Stockholm, Sweden, between
November 2008 and March 2009. The outbreak consisted of 17 neonates that were
colonized with a low-virulence, highly resistant blaCTX-M-15-producing Klebsiella pneu-
moniae (ESBL-KP) strain of sequence type 101 (ST101) (17). Cocolonization was seen
with blaCTX-M-15-producing Escherichia coli in several of the neonates during the 5-year
follow-up period after admission from NICU. The goals of the study were to use optical
DNA mapping to characterize the resistance plasmids throughout the outbreak and
investigate whether the cocolonizing ESBL-producing E. coli were a result of plasmid
transfer during the outbreak.
RESULTS
To identify and characterize plasmids carrying ESBL genes (ESBL-plasmids) and
investigate possible conjugation events, EPE isolates from the outbreak period were
analyzed for plasmid content using the optical DNA mapping protocol summarized in
Fig. 1A. 17 neonates were initially diagnosed as carriers of a multidrug-resistant
blaCTX-M-15-producing strain of ESBL-KP sequence type 101 (ST101) (17). However, only
16 strains were viable after storage and could be included in the molecular analysis. For
seven of the patients, we also investigated ESBL-KP isolates collected at later stages of
the outbreak (6 to 24 months after the first sample was collected), and for four patients,
we investigated blaCTX-M group 1-positive E. coli isolates collected during the follow-up
period (1 to 67 months after the first sample). All isolates, and the time at which they
were collected, are illustrated in Fig. 1B. Patient data can be found in an earlier
publication (17).
K. pneumoniae ST101 at the start of the outbreak. Figure 2 summarizes the
optical mapping results for the 16 ESBL-KP ST101 isolates collected at the start of the
outbreak. Each isolate contained two different plasmids, one with a size of approxi-
mately 80 kbp (Fig. 2, left) and another with a variation in size between 162 and 222
kbp in isolates from different patients (Fig. 2, right; see also Fig. S1 in the supplemental
material). Using the barcodes, we could show that the 80-kbp plasmid from all isolates
was cut by Cas9 at the same location in the presence of guide RNA targeting blaCTX-M
group 1 genes, indicating that this plasmid carried the blaCTX-M-15 gene (see Table S2
in the supplemental material). By comparing the barcodes of the 80-kbp plasmids from
all patients, we could confirm that all these plasmids were identical with a P value of
0.001 or lower. The P values were determined using a set of 1,000 random barcodes,
with sizes corresponding to the two compared barcodes (12). The larger plasmid was
not cut by Cas9 in any isolate, demonstrating that this plasmid did not carry any
blaCTX-M group 1 gene. In order to reveal the barcode, we instead linearized this
plasmid using light-induced DNA breaks (15). While the larger plasmids varied in size
between patient isolates, the barcodes clearly illustrated that they all originated from
the same plasmid. A large identical region (160 kbp) was present in all isolates, but
in three of the isolates, deletions had occurred (patients 3 [5 kbp], 5 [55 kbp], and
8 [31 kbp]). The locations of the deletions are directly visible in the barcodes (Fig. 2,
right). This explains the variation in size and exemplifies how optical mapping reveals
information that is difficult to assess, or is completely hidden, with other techniques.
Taking the deletions into account, we confirmed that all the larger plasmids were of the
same origin, with P values below 0.001.
K. pneumoniae ST101 in follow-up samples. Next, we investigated ESBL-KP iso-
lates from seven of the patients (patients 1, 3, 4, 6, 8, 11, and 13) collected 6 to
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24 months after the initial isolate (see Fig. S2 for plasmid sizes). The 80-kbp plasmid,
carrying the blaCTX-M-15 gene, was present in six of the isolates investigated. For five of
the patients (patients 1, 3, 4, 8, and 11), the 80-kbp plasmids were identical to those at
the first time point with a P value below 0.001. However, for patient 6, visual inspection
of the barcodes suggests that an inversion of about 31 kbp had occurred (dashed
region in Fig. 3). The P value for this pair of plasmids was significantly higher than for
any other combination of 80-kbp plasmids (0.003). The larger plasmid was found in
five of six isolates (absent in the isolate from patient 4) and was again more dynamic
with two isolates containing deletions of 33 kbp (patient 6 [P6]) and 65 kbp (patient 11
[P11]) in size, respectively. For patient 3, the second isolate contained a full 215-kbp
plasmid compared to the initial isolate that had a 5-kbp deletion. The barcodes suggest
that the deletions have occurred in the same general region in all plasmids (Fig. 2 and
3). All P values for these comparisons were again below 0.001. For patient 11, a sample
collected at 26 months showed larger structural variations in the larger plasmid, as can
be seen in Fig. S3.
The isolate from patient 13 (P13K9) collected 9 months after the initial isolate
contained three plasmids with sizes of 72  3.6, 122  6.3, and 204  10.2 kbp. In Fig. 3
(bottom), two of the plasmids are compared with the plasmids in the initial isolate in
patient 13. There is no overlap between these plasmids and also not with the third
plasmid of intermediate size. Furthermore, we did not find a blaCTX-M group 1 gene on
FIG 1 (A) Schematic of the optical DNA mapping protocol used in the study. Plasmids were extracted from cultured bacteria, and the
resistance gene was identified using Cas9 targeting blaCTX-M group 1. The sample was labeled with YOYO and netropsin in a single step
and then introduced into the nanochannels. The plasmids were imaged with a fluorescence microscope, and time traces (kymographs)
representing the optical maps were extracted. Kymographs were used to reveal the number of different plasmids in a sample, their size,
and on which plasmid the blaCTX-M group 1 gene was located (red dot). Optical maps were used to compare plasmids from the different
isolates studied. (B) Overview of the different patients and bacterial isolates analyzed. Each patient is listed on the vertical axis, and
isolation of EPE is illustrated with black boxes (ESBL-KP) and gray circles (ESBL-EC).
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any of these plasmids. This isolate therefore represents a second ESBL-KP that was
unrelated to the outbreak strain.
Genetic characterization of the ESBL-KP ST101 isolates. The optical mapping
method provided an overview of the plasmid content in all ESBL-KP samples investi-
gated. To characterize the genetics of the plasmids in the outbreak clone further, we
used long-read sequencing on the PacBio platform to sequence the plasmid from the
initial ESBL-KP isolate from patient 1 (P1K0). Figure 4 compares the barcodes obtained
using optical mapping with the barcodes predicted from the PacBio sequencing,
demonstrating excellent overlap. The size of the smaller plasmid was 80,272 bp, and the
larger plasmid was 215,872 bp. The position of the blaCTX-M-15 gene on the smaller
plasmid was perfectly predicted from the Cas9 restriction. From the sequence, we
determined that the 80-kbp plasmid contained an IncR and an IncFIA origin and, in
addition to the blaCTX-M-15 gene, also contained genes encoding resistance to -lactams
(blaTEM-1), fluoroquinolones (qnrB1), sulfonamides (sul2), trimethoprim (dfrA14) and
aminoglycosides [aac(3)-IId, aph(6)-Id, aph(3==)-Ib]. The 215-kbp plasmid belonged to
the IncFII group and did not contain any resistance genes but two operons for heavy
metal resistance (arsenic and copper) and several putative virulence genes such as an
urea transport system previously linked to survival in the urinary tract (18). In addition
to the two large plasmids, two small cryptic plasmids of 4,572 bp and 4,163 bp were
present. These plasmids did not contain any resistance or virulence genes. The char-
acteristics of the plasmids are listed in Table S3.
From the complete plasmid sequence, we could also investigate the genetic rear-
rangements found in the 215-kbp plasmid in several of the ESBL-KP ST101 isolates.
Through targeted PCR followed by Sanger sequencing, we could determine the exact
deletion breakpoints. As depicted in Fig. 4B, the endpoints of all deletions were
associated with insertion sequences or transposons. In three isolates (P6K25, P8K0, and
FIG 2 Barcodes of plasmids from the first collected ESBL-KP isolate in each of the 16 patients. (Left)
Barcodes of the 80-kbp plasmid. The vertical black line in the shaded region shows where the Cas9 assay
predicts the location of the blaCTX-M-15 gene. (Right) Barcode of the larger plasmid in each isolate. Note
that there are deletions in three of the plasmids (patient 3 [5 kbp], patient 5 [55 kbp], and patient 8 [31
kbp]). All barcodes were shifted vertically for clarity.
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P8K6), a 29.8-kbp deletion was due to homologous recombination between two
directly repeated IS110 elements. Isolates P3K0 and P5K0 had deletions of 4.7 kbp and
54.9 kbp, respectively, both without obvious homologous regions but with endpoints
close upstream of a Tn3 and an IS26 element, respectively. Most likely, these deletions
were an effect of transposase activity. The sequencing results confirmed the optical
mapping data regarding both position and size of the deletions. For the deletion in
isolate P11K22 and the inversion in the 80 kbp plasmid in isolate P6K25, PCR could not
identify the exact endpoints of the rearrangements.
Investigating potential plasmid conjugation between species. In several of the
patients, ESBL-producing E. coli (ESBL-EC) bacteria were isolated at different time points
FIG 3 Barcodes from follow-up ESBL-KP isolates (black lines) compared to the corresponding first (gray
lines) ESBL-KP ST101 isolate collected. The vertical gray (initial) and black (later) lines in the shaded region
show where the Cas9 assay predicts the location of the blaCTX-M-15 gene. The dashed region indicates the
suggested inversion in sample P6K25. For the larger plasmid regions, 5 to 65 kbp in size are missing in
four of six isolates, and in one isolate, the plasmid is missing completely. P13K9 contained three plasmids,
two of which are shown in the figure and none of the three are the same as the plasmids in the initial
P13K0 isolate. Furthermore, we did not identify a blaCTX-M-15 gene in any of these three plasmids.
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during the follow-up period (Fig. 1B). We analyzed the plasmid content by optically
mapping 14 ESBL-EC isolates from the five patients where the ESBL-EC at least at one
time point dominated the intestinal flora. Figure 5A shows a histogram with the sizes
of the plasmids found in all ESBL-EC isolates. No blaCTX-M-group 1 gene was found on
any of these plasmids, giving a direct indication that the ESBL phenotype of these
isolates had a different genetic origin than the ESBL-KP. Furthermore, there was no
similarity between these plasmids and the plasmids in the ESBL-KP isolates, indicating
that the ESBL-ECs had separate origins.
Ten of the investigated ESBL-EC isolates from patients 3, 6, 7, and 8 had identical
plasmids (P value  0.001; data not shown) with a size of approximately 130 kbp
(Fig. 5B and C; data not shown). PFGE analysis verified that these patients were
colonized by the same ESBL-producing E. coli strain (17). To support the optical DNA
mapping data, we performed PacBio sequencing on one of these isolates (P3E6). This
resulted in one 129,195-bp plasmid of IncFII and IncFIB origin and a small cryptic
plasmid of 5,878 bp. None of these plasmids contained any resistance genes, but the
large plasmid carried putative virulence genes mainly encoding pili and adhesion
proteins (Table S3). The barcode of the 129-kbp plasmid displayed an excellent overlap
with the barcode predicted from sequencing (Fig. S4). The results also demonstrate that
the blaCTX-M-15 gene was located on the E. coli chromosome, in agreement with the lack
of Cas9 cleavage of any plasmids.
Plasmids from one ESBL-EC isolate from patient 6 and three isolates from patient 13
did not match any plasmids from the other ESBL-EC isolates. Cas9 analysis confirmed
that none of these isolates contained any plasmids carrying the blaCTX-M group 1 gene
FIG 4 (A) Comparison of experimental optical map (gray) and theoretical optical map created from PacBio sequencing (black) for the two plasmids in P1K0.
The vertical lines mark the locations of the blaCTX-M-15 gene experimentally determined (gray) and predicted from the theoretical sequence (black). (B) Illustration
of the positions of deletions in several ESBL-KP isolates. The shaded boxed areas indicate the extension of the deletions.
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and none of the plasmids shared any sequence identity between these isolates or the
blaCTX-M-15 plasmid in the ESBL-KP isolates. To illustrate this, the barcodes of these
plasmids were compared with experimental optical maps for the 80-kbp plasmid from
the initial ST101 strain (examples in Fig. 5D to F). When comparing the plasmids in
Fig. 5D to F, they were stretched to the same length, i.e., the average of the two
determined lengths. The only similarity observed between samples was that the
plasmid characterized in Fig. 5B and C showed a significant match (P value  0.01) with
the 152-kbp plasmid in P13E21 (Fig. S5). Since these plasmids did not carry the blaCTX-M
group 1 gene, this was not analyzed further.
FIG 5 (A) Histogram of sizes of plasmids in all E. coli isolates investigated. The dark gray bars represent
isolates carrying the same plasmid, studied in detail in panels B and C. The black hatched bars are isolates
with unique plasmid content, and some of these are shown in panels D to F. The light gray columns are
from the reference ESBL-KP isolate P3K0. (B) Barcodes of the 129-kbp plasmid in the E. coli isolates with
a common plasmid size from different patients (dark gray). The plasmid carrying the blaCTX-M-15 gene in
P3K0 is also shown for comparison (light gray). (C) The 129-kbp plasmid in patient 3 at different time
points. The lines are shifted vertically for clarity. (D to F) Comparisons between the 80-kbp plasmid
carrying the blaCTX-M-15 gene in P3K0 (light gray) and plasmids of similar size in the ESBL-EC isolates
(black).
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The goal of this study was to illustrate the use of optical DNA mapping, including
Cas9-assisted gene identification, for rapid and detailed characterization of plasmids
from bacterial isolates during a resistance outbreak at two NICUs at Karolinska Univer-
sity Hospital in Stockholm, Sweden. The purpose was to characterize the ESBL-plasmids
of the outbreak and reveal whether the presence of several different ESBL-producing
bacterial species was due to horizontal plasmid spread.
With the introduction of the Cas9 protocol, we were able to directly identify on
which plasmid the blaCTX-M group 1 gene was located and through the optical DNA
barcode we could determine whether this particular plasmid was present in any other
isolates during the outbreak. The blaCTX-M group 1 producing plasmid was identical in
all isolates at the start of the outbreak and was also present in children years after
discharge from the NICU. Using optical DNA mapping, we could also show that all
ESBL-EC and one ESBL-KP carried different plasmids than the outbreak ESBL-KP, illus-
trating that these originated from introduction of other ESBL-encoding strains and not
horizontal transfer of the ESBL-plasmid. We demonstrated that four patients carried
ESBL-EC isolates with the same plasmid, suggesting a small second chain of transmis-
sion, but where the blaCTX-M-15 gene was located on the chromosome. We can therefore
conclude that this outbreak was not further complicated by additional plasmid-
mediated spread of resistance. Early identification of transmission of resistant strains is
highly important in any environment, but particularly important in the vulnerable
population of NICU patients. Importantly, while conjugation of plasmids did not occur
in this outbreak, we have demonstrated the potential of the method to detect such
events in previous studies (12–14).
Complementing our analysis with long-read PacBio sequencing of key isolates
demonstrated that the overlap between experimental and theoretical barcodes (15, 19)
was excellent. This comparison confirmed that the location of the blaCTX-M-15 gene
along the barcode of the smaller plasmid, predicted by Cas9 restriction, was correct.
Furthermore, we could reveal information about the plasmids in all ESBL-KP isolates by
performing long-read sequencing on only one key isolate. Long-read sequencing
demonstrated that this plasmid carried several resistance genes in addition to the
blaCTX-M-15. For the larger of the plasmids in the ESBL-KP strain, optical mapping
revealed that large deletions had occurred in several isolates, both at the start of the
outbreak and in follow-up samples, and the positions of these deletions could be
verified from the sequence.
In conclusion, we present a novel method, based on optical DNA mapping, for
detailed characterization of plasmids and their dissemination during a nosocomial
resistance outbreak. The method reveals the number and size of plasmids in bacterial
isolates, a barcode for tracing the plasmids, and the presence and location of any
resistance gene of interest by straightforward design of guide RNA for Cas9 cleavage.
We identified the plasmid carrying the blaCTX-M-15 resistance gene in all isolates and
concluded that no plasmid conjugation had occurred during the outbreak. The com-
bination of optical DNA mapping and long-read sequencing enabled analysis of a large
set of samples by sequencing only key isolates. A novel molecular tool, such as the one
presented herein, could be highly useful for curbing the spread of antimicrobial
resistance in hospitals. Such measures are needed to reach WHÓs Sustainable Devel-
opment Goals for reducing neonatal mortality (2).
MATERIALS AND METHODS
Bacterial samples and molecular analyses. Intestinal EPE were sampled from 17 patients at the
start of the outbreak. Fecal samples were thereafter collected from 14 of the surviving neonates at their
discharge from the NICU and every 2 months until 2 years of age. A 5-year follow-up of EPE colonization
was, due to drop-outs, conducted on 10 children. Rectal agar gel swabs were taken (Copan, Brescia, Italy)
and plated on ChromID ESBL agar (bioMérieux, Craponne, France). Species identification was performed
with Vitek2. The blaCTX-M group was identified with a previously described (20), probe-based PCR assay.
The clinical details of the outbreak are published elsewhere (17). The study was approved by the regional
ethical review board in Stockholm, Sweden (2009/734-31/4 and 2014/491-31/3).
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Optical DNA mapping of plasmids. Bacteria were grown in 100-ml overnight cultures in LB broth,
and plasmids were prepared from the cultures using the Macherey-Nagel NucleoBond Xtra Midi
preparation kit according to the manufacturer’s instructions. Eluted plasmid DNA was precipitated with
isopropanol, and resuspended in 1 TE buffer. Plasmids were treated with Cas9 and guide RNA (gRNA)
targeting blaCTX-M group 1 by following our previously reported protocol (16). Plasmids and  DNA (New
England Biolabs) at equal concentrations were stained with YOYO-1 (Invitrogen) at a molar ratio of 1:2
(YOYO-1:bp) and with netropsin (Sigma-Aldrich) at a molar ratio of 100:1 (netropsin:YOYO-1) to obtain
the DNA barcode.  DNA was used as an internal size reference (48,500 bp). DNA (2 M) was incubated
with YOYO-1 and netropsin in 10 l of 0.5 TBE at 50°C for 30 to 60 min in order to achieve uniform
staining (21). Samples were diluted with Millipore water to obtain a final concentration of 0.05 TBE and
0.2 M (bp) of DNA. To suppress photo nicking and photo bleaching of DNA molecules, 2.5% (vol/vol)
of -mercaptoethanol (BME) was added to the solution.
Nanofluidic channels were fabricated in oxidized silicon, as described elsewhere (22). Nanochannels
of dimensions 100 nm by 150 nm2 and a length of 500 m were used to stretch the DNA molecules. Prior
to loading the samples, the channels were cleaned with a 5% (wt/wt) sodium hypochlorite solution and
then washed a few times with loading buffer (0.05 TBE). By cleaning with sodium hypochlorite solution
and washing with buffer, some nanofluidic chips were used more than 50 times, and on average, each
section of the chip was used at least 10 times. Fifteen microliters of DNA solution was placed in one of
the reservoirs, and DNA molecules were forced into the nanochannels by applying pressure with
nitrogen gas. An inverted microscope (Zeiss AxioObserver.Z1) equipped with either a 63 (with 1.6 times
optovar) or 100 oil immersion objective (Zeiss) (numerical aperture [NA] of 1.46) and an electron-
multiplying charge-coupled-device (EMCCD) camera (Photometrics Evolve or Andor iXon) was used to
image the DNA molecules. Both circular and linear molecules were stretched in the nanochannels and
imaged for 200 frames with 100-ms exposure time.
The data were analyzed in order to detect the number of plasmids in each sample, their correspond-
ing size, as well as their sequence-specific barcode and potential presence of a resistance gene (blaCTX-M
group 1). In short, the internal size reference  DNA was used in order to estimate the plasmid size, either
directly from linearized plasmids, or from plasmids in their circular form, using a conversion factor of 1.8
(23). Linear fragments of similar size (10%), obtained either by Cas9 linearization, or via extensive light
exposure (15), were compared, and individual barcodes with a high degree of similarity (typically Pearson
cross correlation [CC] of 0.75) were merged into a consensus barcode. The consensus barcode was used
both for comparison between different isolates, rendering a P value (12), as well as for detecting the
presence of a resistance gene, by studying the positions of the double-strand breaks of the individual
plasmid barcodes within the consensus barcode (16).
Whole-genome sequencing and bioinformatics. Complete genomic DNA (chromosomal DNA and
plasmids) was isolated using the Qiagen Genomic-tip 100 kit according to the manufacturer’s instruc-
tions. PacBio Sequencing was performed at the Science for Life Laboratory in Uppsala, Sweden, on a RSII
system with one SMRT cell per genome. Illumina MiSeq sequencing was performed with two times
300-bp paired-end read lengths using Nextera XT DNA Library preparation kit (Illumina) according to the
manufacturer´s instructions. The overall combined chromosomal coverage generated was 25-fold for
all isolates.
De novo assembly was performed for each data set with the CLC Genomics workbench v.10 (CLC Bio,
Aarhus, Denmark) including the CLC Microbial Genomics Module 3.0. Contig sequences from the PacBio
sequencing were used as references for assembly of the Illumina reads, and the resulting contigs were
circularized by detection of redundant end sequences and by mate-pair analysis. To verify that no
plasmids were missed between isolates, de novo assembly of nonmatched reads from combined
reference assemblies for each data set was performed, and remaining contigs were subjected to BLASTn
searches and analyzed for gene content. The NCBI Prokaryotic Genome Annotation Pipeline was used for
complete genome annotation. Detection of resistance genes, plasmid replicons, and virulence genes was
done by submitting de novo-assembled contigs for each isolate to the online resources ResFinder (24),
PlasmidFinder (25), and VirulenceFinder (26), respectively, at the Center for Genomic Epidemiology, DTU,
Denmark.
PCR. PCR with primers flanking potential deletion breakpoints on the plasmids was performed.
Amplification was done using purified plasmids as the template with the following procedure: initial
denaturation at 98°C for 3 min, followed by 25 rounds of PCR with 1 round consisting of amplification
by denaturation at 98°C for 30 s, annealing at 57°C for 30 s, and elongation at 72°C for 30 s. PCR products
were analyzed on an agarose gel and visualized under UV light after ethidium bromide staining. PCR
products were purified using ThermoFisher Scientific GeneJET Gel Extraction kit according to the
manufacturer’s instructions and sent for Sanger sequencing at Eurofins Genomics (Germany) using
the same primers as for the quantification of the deletion breakpoints. Primers are listed in Table S1 in
the supplemental material.
Data availability. All sequences have been deposited at GenBank under BioProject PRJNA427077
with accession numbers CP025576 to CP025580.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00347-19.
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